Clinical Trials
8
Active:0
Completed:5
Trial Phases
1 Phases
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (100.0%)A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
Not Applicable
Recruiting
- Conditions
- Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial Fibrillation
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-06-16
- Lead Sponsor
- Kardium Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT06973031
- Locations
- 🇩🇪
Westpfalz-Klinikum GmbH Kaiserslautern, Kaiserslautern, Germany
Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
Not Applicable
Recruiting
- Conditions
- Persistent Atrial FibrillationParoxysmal Atrial Fibrillation
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2025-07-04
- Lead Sponsor
- Kardium Inc.
- Target Recruit Count
- 549
- Registration Number
- NCT05462145
- Locations
- 🇺🇸
Texas Cardiac Arrhythmia Research Foundation, Austin, Texas, United States
🇺🇸University of Alabama Heersink School of Medicine, Birmingham, Alabama, United States
🇺🇸Grandview Medical Center, Birmingham, Alabama, United States
Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
Not Applicable
Recruiting
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2025-06-16
- Lead Sponsor
- Kardium Inc.
- Target Recruit Count
- 175
- Registration Number
- NCT05164107
- Locations
- 🇨🇿
Nemocnice Na Homolce, Praha, Czechia
Clinical Performance of the Globe® Mapping and Ablation System for the Treatment of Atrial Fibrillation
Completed
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2021-07-08
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Kardium Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT04954911
- Locations
- 🇩🇪
Herz- und Diabeteszentrum NRW, Bad Oeynhausen, North Rhine-Westphalia, Germany
🇩🇪Herzzentrum Leipzig, Leipzig, Saxony, Germany
Performance and Safety of the Globe® Mapping and Ablation System With the GPS™ Module for the Treatment of Atrial Fibrillation
Not Applicable
Completed
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Kardium Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT04486924
- Locations
- 🇨🇦
Southlake Regional Health Centre, Newmarket, Canada
🇨🇦St. Paul's Hospital, Vancouver, Canada
- Prev
- 1
- 2
- Next
News
No news found